Advertisement
Research Article

Why Do HIV-1 and HIV-2 Use Different Pathways to Develop AZT Resistance?

  • Paul L Boyer,

    Affiliation: HIV Drug Resistance Program, NCI-Frederick, Frederick, Maryland, United States of America

    X
  • Stefan G Sarafianos,

    Affiliation: Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey, United States of America

    X
  • Patrick K Clark,

    Affiliation: Basic Research Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, United States of America

    X
  • Eddy Arnold,

    Affiliation: Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey, United States of America

    X
  • Stephen H Hughes mail

    To whom correspondence should be addressed. E-mail: hughes@ncifcrf.gov

    Affiliation: HIV Drug Resistance Program, NCI-Frederick, Frederick, Maryland, United States of America

    X
  • Published: February 17, 2006
  • DOI: 10.1371/journal.ppat.0020010

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.